These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 6401349)

  • 1. Oral administration of urea cycle intermediates in lysinuric protein intolerance: effect on plasma and urinary arginine and ornithine.
    Rajantie J; Simell O; Perheentupa J
    Metabolism; 1983 Jan; 32(1):49-51. PubMed ID: 6401349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective metabolic clearance of plasma arginine and ornithine in lysinuric protein intolerance.
    Simell O; Perheentupa J
    Metabolism; 1974 Aug; 23(8):691-701. PubMed ID: 4851276
    [No Abstract]   [Full Text] [Related]  

  • 3. "Basolateral" and mitochondrial membrane transport defect in the hepatocytes in lysinuric protein intolerance.
    Rajantie J; Simell O; Perheentupa J
    Acta Paediatr Scand; 1983 Jan; 72(1):65-70. PubMed ID: 6407277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral supplementation corrects plasma lysine concentrations in lysinuric protein intolerance.
    Lukkarinen M; Näntö-Salonen K; Pulkki K; Aalto M; Simell O
    Metabolism; 2003 Jul; 52(7):935-8. PubMed ID: 12870174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocitrullinuria and homoargininuria in lysinuric protein intolerance.
    Kato T; Sano M; Mizutani N
    J Inherit Metab Dis; 1989; 12(2):157-61. PubMed ID: 2474087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperammonemia in lysinuric protein intolerance.
    Kato T; Mizutani N; Ban M
    Pediatrics; 1984 Apr; 73(4):489-92. PubMed ID: 6424086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lysinuric protein intolerance].
    Behbehani AW; Gahr M; Schröter W
    Monatsschr Kinderheilkd; 1983 Nov; 131(11):784-7. PubMed ID: 6420670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lysinuric protein intolerance: a severe hyperammonemia secondary to l-arginine deficiency (author's transl)]].
    Coude FX; Ogier H; Charpentier C; Cathelineau L; Grimber G; Parvy P; Saudubray JM; Frezal J
    Arch Fr Pediatr; 1981 Dec; 38 Suppl 1():829-35. PubMed ID: 6800334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysinuric protein intolerance.
    Simell O; Perheentupa J; Rapola J; Visakorpi JK; Eskelin LE
    Am J Med; 1975 Aug; 59(2):229-40. PubMed ID: 1155480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of ornithine metabolism in hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome, lysinuric protein intolerance and gyrate atrophy fibroblasts.
    Botschner J; Smith DW; Simell O; Scriver CR
    J Inherit Metab Dis; 1989; 12(1):33-40. PubMed ID: 2501580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysinuric protein intolerance. Basolateral transport defect in renal tubuli.
    Rajantie J; Simell O; Perheentupa J
    J Clin Invest; 1981 Apr; 67(4):1078-82. PubMed ID: 7204568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysinuric protein intolerance. Urinary amino acid excretion at 2 and 9 days of age.
    Candito M; Vianey-Saban C; Ferraci JP; Bébin B; Chazalette JP; Sebag F; Mathieu M; Chambon P
    J Inherit Metab Dis; 1994; 17(2):252-3. PubMed ID: 7967486
    [No Abstract]   [Full Text] [Related]  

  • 13. Improving a Rare Metabolic Disorder Through Kidney Transplantation: A Case Report of a Patient With Lysinuric Protein Intolerance.
    IJzermans T; van der Meijden W; Hoeks M; Huigen M; Rennings A; Nijenhuis T
    Am J Kidney Dis; 2023 Apr; 81(4):493-496. PubMed ID: 36223829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced nitric oxide production by L-arginine deficiency in lysinuric protein intolerance exacerbates intravascular coagulation.
    Kayanoki Y; Kawata S; Yamasaki E; Kiso S; Inoue S; Tamura S; Taniguchi N; Matsuzawa Y
    Metabolism; 1999 Sep; 48(9):1136-40. PubMed ID: 10484053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The dibasic amino acid metabolic disorders].
    Shimizu H
    Nihon Rinsho; 1992 Jul; 50(7):1555-60. PubMed ID: 1404883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutrient intake in lysinuric protein intolerance.
    Tanner LM; Näntö-Salonen K; Venetoklis J; Kotilainen S; Niinikoski H; Huoponen K; Simell O
    J Inherit Metab Dis; 2007 Oct; 30(5):716-21. PubMed ID: 17588131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysinuric protein intolerance with thymic hypoplasia.
    Hasanoğlu A; Dílek EO; Memíş L; Biberoğlu G
    J Inherit Metab Dis; 1996; 19(3):372-3. PubMed ID: 8803785
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of lysine infusion on urea cycle in lysinuric protein intolerance.
    Lukkarinen M; Näntö-Salonen K; Pulkki K; Mattila K; Simell O
    Metabolism; 2000 May; 49(5):621-5. PubMed ID: 10831173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal handling of diamino acids in lysinuric protein intolerance.
    Simell O; Perheentupa J
    J Clin Invest; 1974 Jul; 54(1):9-17. PubMed ID: 4600043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysinuric protein intolerance presenting deficiency of argininosuccinate synthetase.
    Ono N; Kishida K; Tokumoto K; Watanabe M; Shimada Y; Yoshinaga J; Fujii M
    Intern Med; 1992 Jan; 31(1):55-9. PubMed ID: 1568044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.